Literature DB >> 921443

Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.

P Serra, C Brandimarte, P Martino, S Carlone, G Giunchi.   

Abstract

Combinations of penicillin G sodium or ampicillin plus streptomycin sulfate do not produce synergism against all strains of enterococci. This lack of synergism was considered the cause of the failure in the treatment of enterococcal endocarditis. The effect of various combinations of antibiotics on 15 enterococcus strains, which had been isolated from patients with enterococcal endocarditis, was examined. The antibiotics included those that interfere with cell-wall synthesis and those that act on cell metabolism. The in vitro results have shown that while penicillin- or ampicillin-streptomycin combination was not synergistic in eight of 15 strains, penicillin- or ampicillin-gentamicin sulfate combination was synergistic in 100% of the cases. We report seven cases of enterococcal endocarditis that were successfully treated with penicillin- or ampicillin-gentamicin combination, thus confirming the effectiveness of this therapeutic regimen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921443

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Enterococcal endocarditis: can we win the war?

Authors:  Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Antimicrobial susceptibilities of enterococci isolated from hospitalized patients.

Authors:  M Venditti; A Tarasi; V Gelfusa; E Nicastri; A Penni; P Martino
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

3.  Group C streptococcal endocarditis: case report and review of the literature.

Authors:  D S Stein; A P Panwalker
Journal:  Infection       Date:  1985 Nov-Dec       Impact factor: 3.553

4.  Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.

Authors:  D J Krogstad; A R Pargwette
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  Enterococcal endocarditis: duration and mode of treatment.

Authors:  R Tompsett; W Berman
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

6.  Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.

Authors:  Martin E. Stryjewski; Vivian H. Chu; Christopher H. Cabell; Vance G. Fowler
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

7.  Teicoplanin in the treatment of gram-positive-bacterial endocarditis.

Authors:  P Martino; M Venditti; A Micozzi; C Brandimarte; G Gentile; C Santini; P Serra
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 8.  Parenteral aminoglycoside therapy. Selection, administration and monitoring.

Authors:  C R Kumana; K Y Yuen
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

9.  Value addition in the efficacy of conventional antibiotics by Nisin against Salmonella.

Authors:  Aman Preet Singh; Vijay Prabha; Praveen Rishi
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

10.  Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases.

Authors:  Rizwan Aslam; Céline Marban; Christian Corazzol; François Jehl; François Delalande; Alain Van Dorsselaer; Gilles Prévost; Youssef Haïkel; Corinne Taddei; Francis Schneider; Marie-Hélène Metz-Boutigue
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.